Herbert Y. Lin
Direktor/Vorstandsmitglied bei FerruMax Pharmaceuticals, Inc.
Ursprung des Netzwerks ersten Grades von Herbert Y. Lin
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
FerruMax Pharmaceuticals, Inc.
FerruMax Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FerruMax Pharmaceuticals, Inc. engages in the business of pharmaceutical preparations. The private company is based in Sherbon, MA.
4
| Private Company | Pharmaceuticals: Major | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Herbert Y. Lin
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Avicena Group, Inc.
Avicena Group, Inc. Pharmaceuticals: MajorHealth Technology Avicena Group, Inc. develops pharmaceuticals and skin care products. It focuses on developing products based on its proprietary understanding of the regulation of cellular energy processes. The company's core technologies have broad applications in both pharmaceuticals and dermaceuticals. Avicena Group was founded by Rima Kaddurah-Daouk and M. Flint Beal in 1989 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. Medical/Nursing ServicesHealth Services Aspen Neuroscience, Inc. engages in the provision of neurological treatment services. It offers technologies for patient-specific induced pluripotent stem cell-based therapies. The company was founded by Jeanne Loring and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member | |
The University of Texas at Austin | College/University | Doctorate Degree | |
SANA BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member | |
Locanabio, Inc.
Locanabio, Inc. Packaged SoftwareTechnology Services Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA. | Packaged Software | Chairman | |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal | |
LARIMAR THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Analyst | |
Lupus Research Alliance, Inc.
Lupus Research Alliance, Inc. Miscellaneous Commercial ServicesCommercial Services Lupus Research Alliance, Inc. provides research and development for the treatment of lupus disease. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Mozart Therapeutics, Inc.
Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | Biotechnology | Director/Board Member | |
ImmusanT, Inc.
ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member | |
AMBRX INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Trotana, Inc.
Trotana, Inc. BiotechnologyHealth Technology Trotana, Inc. discovers and develops medicines. The company is based in San Diego, CA. The CEO of the company is Hamza Suria. | Biotechnology | Chairman | |
Life Science Cares San Diego LLC | Corporate Officer/Principal | ||
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | Pharmaceuticals: Major | Founder | |
The Reed Institute | College/University | Director/Board Member | |
GOSSAMER BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
WorldCare, Inc. (Massachusetts)
WorldCare, Inc. (Massachusetts) Medical/Nursing ServicesHealth Services WorldCare, Inc. develops and commercializes global healthcare services and solutions. The firm’s services include worldcare ACCESS, worldcare ALLY, worldcare TRAVELER, worldcareMD, worldcare CONCIERGE, worldcare expert medical resources, worldcare consulting and management. The company was founded in 1996 and is headquartered in Boston, MA. | Medical/Nursing Services | Chief Executive Officer | |
The University of Texas Southwestern Medical Center | College/University | Doctorate Degree | |
The University of Chicago | College/University | Undergraduate Degree | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin | |
CELGENE | Biotechnology | President | |
EPIZYME, INC. | Biotechnology | Director/Board Member | |
PharmAkea, Inc.
PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member | |
Abide Therapeutics, Inc.
Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | Pharmaceuticals: Other | Director/Board Member | |
JUNO THERAPEUTICS INC | Biotechnology | Director/Board Member | |
Southern Methodist University
Southern Methodist University Other Consumer ServicesConsumer Services Southern Methodist University is a private university near the center of Dallas, SMU offers undergraduate, graduate, and professional programs through seven schools in the humanities and sciences, business, the performing, visual, and communication arts, engineering, education and human development, law, and theology. | College/University | Undergraduate Degree | |
Vanderbilt Vascular Biology Center
Vanderbilt Vascular Biology Center Miscellaneous Commercial ServicesCommercial Services Vanderbilt Vascular Biology Center operates a biology center. The private company is based in Nashville. | Miscellaneous Commercial Services | Director/Board Member | |
AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Corporate Officer/Principal | |
Vanderbilt University | College/University | Corporate Officer/Principal | |
VIR BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member | |
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Catalyst Advisors LP | Director/Board Member | ||
Nocion Therapeutics, Inc.
Nocion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nocion Therapeutics, Inc. is a biopharmaceutical company, which targets neurons mediating cough, itch, pain and inflammation without the addictive properties of opioids. The company was founded by Bruce Bean, Clifford Woolf and Bruce David Levy and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder |
Statistik
International
Vereinigte Staaten | 43 |
Sektoral
Health Technology | 24 |
Consumer Services | 9 |
Commercial Services | 5 |
Health Services | 3 |
Finance | 3 |
Operativ
Director/Board Member | 28 |
Corporate Officer/Principal | 7 |
Independent Dir/Board Member | 6 |
Chairman | 4 |
Chief Tech/Sci/R&D Officer | 4 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Thomas Daniel | 35 |
Clifford J. Woolf | 6 |
Nasser Menhall | 5 |
Leslie S. T. Fang | 2 |
- Börse
- Insiders
- Herbert Y. Lin
- Unternehmensverbindungen